Gyamfi Cynthia, Berkowitz Richard L
Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, Mount Sinai School of Medicine, New York, New York 10029, USA.
Obstet Gynecol. 2004 Sep;104(3):541-4. doi: 10.1097/01.AOG.0000135276.25886.8e.
To review the treatment options presented on the New York State Health Care Proxy for Jehovah's Witnesses, which is signed by pregnant women when they present for care.
Chart reviews were performed for all women who presented to labor and delivery at our institution from 1997 to 2002 and identified themselves as Jehovah's Witnesses. A patient was included in the study if a completed health care proxy was available in her chart. Data were derived from the health care proxy and from the Mount Sinai School of Medicine's Blood Product Checklist for Jehovah's Witness Patients. Variables of interest included age, race, parity, and antenatal and perinatal complications.
A total of 61 patients were identified. Of these, 39.3% agreed to accept a variety of donated blood products, 9.8% would accept donated packed red blood cells, and 50.1% would accept neither from a homologous donor. With respect to nonstored autologous blood, 55% of respondents would accept either intraoperative normovolemic hemodilution or transfusion of their own blood obtained by a cell salvage system. No significant differences in responses were noted for any of the above-mentioned variables.
This review refutes the commonly held belief that all Jehovah's Witnesses refuse to accept blood or any of its products. In this population of pregnant women, the majority were willing to accept some form of blood or blood products. This information can be used to help health care providers counsel a patient when she is initially faced with considering these issues and may help to remove the stigma of accepting one of the options.
回顾纽约州耶和华见证会医疗保健代理人表格中列出的治疗方案,该表格由前来就诊的孕妇签署。
对1997年至2002年期间在我院产科分娩且自认为是耶和华见证会信徒的所有女性进行病历审查。如果病历中有完整的医疗保健代理人表格,则将该患者纳入研究。数据来自医疗保健代理人表格以及西奈山医学院耶和华见证会患者血液制品清单。感兴趣的变量包括年龄、种族、产次以及产前和围产期并发症。
共识别出61例患者。其中,39.3%的患者同意接受多种捐赠血液制品,9.8%的患者愿意接受捐赠的浓缩红细胞,50.1%的患者既不接受来自同源供体的血液制品。对于非储存自体血,55%的受访者愿意接受术中正常血容量血液稀释或接受通过细胞回收系统获取的自身血液输血。上述任何变量的回答均未发现显著差异。
本综述反驳了普遍认为的所有耶和华见证会信徒都拒绝接受血液或其任何制品的观点。在这群孕妇中,大多数人愿意接受某种形式的血液或血液制品。这些信息可用于帮助医疗保健提供者在患者最初面临这些问题时为其提供咨询,并可能有助于消除接受其中一种选择的污名。